In coordination with the FDA, the multinational is withdrawing the acne treatment Effaclar Duo from the La Roche-Posay brand. The cosmetic multinational L'Oreal has been forced to withdraw a product ...

The FDA said testing of certain acne products with benzoyl peroxide found elevated levels of benzene, a chemical linked to cancer.

The products, which contain benzoyl peroxide, a common treatment for acne, were tested for elevated levels of benzene, the U.S. Food and Drug Administration (FDA) said in a notice this week.

Benzoyl peroxide is one of the most effective and commonly used acne treatments. You’ll find it in prescription and non-prescription acne medications. It’s also found in medications used to treat ...

The products contain benzoyl peroxide, which can produce the carcinogen benzene under certain conditions Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in ...

Benzoyl peroxide has antibacterial activity ... Improvement may not occur for up to 4 months following the start of therapy. A combination of nicotinamide (750 mg), zinc oxide (25 mg), and ...

The recall primarily affects over-the-counter acne treatment products containing benzoyl peroxide. Retailers are instructed to remove products from store shelves and online marketplaces.

In early 2024, Valisure, an independent laboratory testing firm, found benzoyl peroxide — the active ingredient in certain acne treatments — can degrade into varying levels of benzene.

The US formulation of Effaclar Duo contains the ingredient benzoyl peroxide (BPO), which kills bacteria to help treat acne. The recall does not affect the UK as the substance is not present in ...